HOME PEOPLE PUBLICATIONS ONGOING PROJECTSMODELSCOURSES

JOURNAL PUBLICATIONS

    **Policy citations

  1. Gopalappa, C., Farnham, P.G., Chen, Y-H., and Sansom, S.L. Progression and Transmission of HIV/AIDS (PATH 2.0): A New Agent-Based Model to Estimate HIV Transmissions in the United States, Med Decis Making 2017 Feb;37(2):224-233. doi: 10.1177/0272989X16668509 LINK
  2. Eaton, J., Bacaër, N., Bershteyn, A., Cambiano, V., Cori, A., Dorrington, R.E., Fraser, C., Gopalappa, C., Hontelez, J.A.C., Johnson, L.F., Klein, D.J., Phillips, A.N., Pretorius, C., Stover, J., Rehle, T.M., Hallett, T.B., Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era, The Lancet Global Health, Vol 3, e598, October 2015; DOI: http://dx.doi.org/10.1016/S2214-109X(15)00080-7; LINK

  3. Stover, J., Andreev, K., Slaymaker, E., Gopalappa, C., Sabin, K., Velasquez, C., Nakiyingi-Miiro, J., Crampin, A., Lutalo, T., Herbst, K., Gregson, S., and Urassa, M., Updates to the Spectrum model to estimate key HIV indicators for adults and children, AIDS 2014, 28 (Suppl 4):S427–S434 PDF
  4. Gopalappa, C., Stover, J., Shaffer, N., and Mahy, M., The Costs and Benefits of Option B+ for the Prevention of Mother-to-Child Transmission of HIV, AIDS, 28 Suppl. 1:S5-14, 2014 LINK
  5. Stover, J., Hallett, T., Wu, Z., Warren, M., Gopalappa, C., Pretorius, C., Ghys, P.D., Montaner, J., Schwartländer, B.; New Prevention Technology Study Group, How can we go to Zero? The Potential Contribution of Biomedical Prevention and the Investment Framework towards an Effective Response to HIV, PLoS One, 9(11):e111956, 2014 PDF
  6. Stover, J., Gopalappa, C., Mahy, M., Doherty, M.C., Easterbrook, P.J., Weiler, G., and Ghys, P.D., The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy, AIDS, 28 Suppl. 2:S225-30, 2014 PDF

  7. Gopalappa, C., Huang, Y., Melanie, T., Kwame, O., and Gift, T., Cost-effectiveness of screening men in Maricopa County jails for chlamydia and gonorrhea to avert infections in women, STD, 40 (10):776-783, 2013 MODEL
  8. Pretorius, C., Menzies, N.A., Chindelevitch, L., Cohen, T., Cori, A., Eaton, J. A., Fraser, C., Gopalappa, C., Hallett, T. B., Salomon, J. A., Stover, J., White, R. G., Dodd, P. J., The potential effects of changing HIV treatment policy on TB outcomes in South Africa: results from three TB-HIV transmission models, AIDS, 28 Suppl 1:S25-34, 2014
  9. Eaton, J., Menzies, N., Stover, J., Cambiano, V., Chindelevitch, L., Cori, A., Hontelez, J. A. C., Humair, S., Kerr C. C., Klein, D J., Mishra, S., Mitchell, K. M., Nichols, B.E., Vickerman, V., Bakker, R., Barnighausen, T., Bershteyn, A., Bloom, D.E., Boily, M-C, Chang, S.T., Cohen, T., Dodd, P.J., Fraser, C., Gopalappa, C., Lundgren, J., Martin, N.K., Mikkelsen, E., Mountain, E., Pham, Q.D., Pickles, M., Phillips, A., Platt, L., Pretorius, C., Prudden, H.J., Salomon, J.A., van de Vijver, D.A.M.C., de Vlas, S. J., Wagner, B. G., White, R.G., Wilson, D.P., Zhang, L., Blandford, J., Meyer-Rath, G., Remme, M., Revill, P., Sangrujee, N., Terris-Prestholt, F., Doherty, M., Shaffer, N., Easterbrook, P.J., Hirnschall, G., Hallett, T.B., How should HIV programmes respond to evidence for the benefits of earlier treatment initiation? A combined analysis of twelve mathematical models, Lancet Global Health, 2(1):e23, 2014
  10. Farnham, P., Gopalappa, C., Sansom, S., Costs and effectiveness of early versus late treatment in view of recent guidelines for starting treatment at an earlier HIV stage, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, JAIDS, 64(2):183-189, 2013. MODEL
  11. Farnham, P.G., Holtgrave, D. R., Gopalappa, C., Angela B. Hutchinson, Stephanie L. Sansom, Lifetime Costs and QALYs Saved from HIV Prevention in the Test and Treat Era, Letter to the Editor, JAIDS, 64(2):e15-e18, 2013
  12. Gopalappa, C., Stover, J., and Pretorius, C., HIV prevalence patterns by age: Exploring differences among 19 countries, DHS Analytical Studies, No. 40. Calverton, Maryland, USA: ICF International, 2013.
  13. Gopalappa, C., Farnham, P., Hutchinson, A., and Sansom, S., Cost-effectiveness of the National HIV/AIDS Strategy (NHAS) goal of increasing the proportion linking to care at diagnosis, JAIDS, 61 (1):99-105, 2012.
  14. ...

  15. Gopalappa, C., Cremaschi, S., Das, T., Orcun, S., Applied Probability Models for Estimating Progression Rates between Colorectal Cancer Stages, Health Care Management Science 14(1), March 2011: Pg 1-21 pdf
  16. ...

  17. Gopalappa, C., Das, T., Enkemann, S., and Eschrich, S., Removal of Hybridization and Scanning Noise from Microarrays, IEEE Transactions on Nanobioscience, 8(3), 2009
SELECTED TALKS

  1. Chaitra Gopalappa, PhD, Analyses of national and global strategic plans for disease prevention and control, Kavli Frontiers of Science symposia, National Academy of Sciences, Irvine, California, December 2016 details

  2. Buyannemekh Munkhbat* , A multi-dimensional evolving contact network approach for modeling dynamics of contagious disease spread, Poster Presentation, IALS launch event, October 31st, 2016

  3. Brooke Herzog* Simulation modeling of disease transmission, Tutorial Session, Summer Engineering Institute (SENGI), July 13th 2015

  4. Mike McGrath*,'Methodology for Estimating the Burden of Breast Cancer and Impact of Screening: In Low and Middle Income Countries', poster presentation, Center for Data Science Launch Symposium, UMass April 9th 2015

    * Student

HOME